Robbins Andrew R 4/A
4/A · Harpoon Therapeutics, Inc. · Filed May 14, 2021
Insider Transaction Report
Form 4/AAmended
Robbins Andrews R
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 totalExercise: $23.20Exp: 2031-05-03→ Common Stock (10,167 underlying)
Footnotes (2)
- [F1]This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error.
- [F2]The stock option will fully vest and become exercisable on May 3, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date. The original Form 4 filed on May 7, 2021 erroneously reported this vesting date as May 4, 2022.